X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (13) 13
female (10) 10
animals (9) 9
adult (6) 6
abridged index medicus (5) 5
male (5) 5
middle aged (5) 5
physiological aspects (5) 5
research (5) 5
aged (4) 4
drosophila (4) 4
gene expression (4) 4
genetic aspects (4) 4
kinases (4) 4
multidisciplinary sciences (4) 4
mutation (4) 4
article (3) 3
cardiac & cardiovascular systems (3) 3
catheter ablation (3) 3
chemistry (3) 3
colony-stimulating factor (3) 3
follow-up studies (3) 3
heterocyclic compounds (3) 3
human necessities (3) 3
hygiene (3) 3
medical or veterinary science (3) 3
metallurgy (3) 3
models, molecular (3) 3
oncology (3) 3
organic chemistry (3) 3
preparations for medical, dental, or toilet purposes (3) 3
protein kinase inhibitors - pharmacology (3) 3
tachycardia, atrioventricular nodal reentry - physiopathology (3) 3
tachycardia, atrioventricular nodal reentry - surgery (3) 3
treatment outcome (3) 3
tumors (3) 3
aminopyridines - chemistry (2) 2
aminopyridines - pharmacology (2) 2
apoptosis - physiology (2) 2
apoptosis - radiation effects (2) 2
base sequence (2) 2
biochemistry & molecular biology (2) 2
braf (2) 2
c-myc (2) 2
cancer (2) 2
care and treatment (2) 2
cell biology (2) 2
cell line, tumor (2) 2
cells (2) 2
dna damage (2) 2
domain (2) 2
drosophila transposon p-element piggybac mutagenesis (2) 2
enzyme activation - drug effects (2) 2
expression (2) 2
gene mutations (2) 2
gene-expression (2) 2
genes (2) 2
health aspects (2) 2
indoles - adverse effects (2) 2
macrophage colony-stimulating factor (2) 2
macrophages (2) 2
management (2) 2
map kinase signaling system - drug effects (2) 2
melanoma (2) 2
mice (2) 2
molecular sequence data (2) 2
mutation - genetics (2) 2
mutations (2) 2
nf-kappa-b (2) 2
pregnancy (2) 2
programmed cell-death (2) 2
prospective studies (2) 2
protein kinase inhibitors - chemistry (2) 2
proto-oncogene proteins b-raf - antagonists & inhibitors (2) 2
proto-oncogene proteins b-raf - genetics (2) 2
pyrroles - chemistry (2) 2
pyrroles - pharmacology (2) 2
reaper gene (2) 2
research article (2) 2
resistance (2) 2
rheumatoid-arthritis (2) 2
solid tumors (2) 2
studies (2) 2
sulfonamides - adverse effects (2) 2
surgery (2) 2
therapeutic target (2) 2
therapy (2) 2
tumor suppressor genes (2) 2
tumor suppressor protein p53 - metabolism (2) 2
tumor-suppressor (2) 2
tyrosine kinase (2) 2
ventricular function, left - physiology (2) 2
3rd chromosome (1) 1
abl (1) 1
ablation (1) 1
accuracy (1) 1
acquired-resistance (1) 1
activation (1) 1
acute myeloid-leukemia (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 09/2010, Volume 467, Issue 7315, pp. 596 - 599
B-RAF is the most frequently mutated protein kinase in human cancers. The finding that oncogenic mutations in BRAF are common in melanoma, followed by the... 
ACTIVATION | PATHWAY | MULTIDISCIPLINARY SCIENCES | MUTATION | KERATOACANTHOMAS | SENSITIVITY | SENESCENCE | SORAFENIB | HUMAN CANCER | PROGRESSION | BRAF(V600E) | Humans | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Macaca fascicularis | Melanoma - enzymology | Substrate Specificity | Positron-Emission Tomography | Extracellular Signal-Regulated MAP Kinases - metabolism | Indoles - administration & dosage | Neoplasm Metastasis | Melanoma - genetics | Phosphorylation - drug effects | Mutant Proteins - antagonists & inhibitors | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Sulfonamides - chemistry | Mutant Proteins - genetics | Models, Molecular | Rats | Mutant Proteins - metabolism | Melanoma - pathology | Mutation - genetics | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Animals | Indoles - adverse effects | MAP Kinase Signaling System - drug effects | Sulfonamides - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Mutant Proteins - chemistry | Alleles | Dogs | Sulfonamides - adverse effects | Indoles - therapeutic use | Indoles - chemistry | Sulfonamides - administration & dosage | Control | Gene mutations | Melanoma | Development and progression | Genetic aspects | Research | Health aspects | Protein kinases | Cancer | Proteins | Mutation | Kinases | Rodents | Index Medicus | targeted therapy | melanoma | BRAF | PLX4032 | biomarker | oncogene
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7574, pp. 583 - 586
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 5, pp. 428 - 437
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 02/2004, Volume 24, Issue 3, pp. 1219 - 1231
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2013, Volume 110, Issue 14, pp. 5689 - 5694
Inflammation and cancer, two therapeutic areas historically addressed by separate drug discovery efforts, are now coupled in treatment approaches by a growing... 
Receptors | Kidneys | Bones | Osteoclasts | Mast cells | Arthritis | Macrophages | Inhibitory concentration 50 | Tumors | Cancer | CSF1R | Cancer bone metastasis | Rheumatoid arthritis | Scaffold-based drug design | CHRONIC MYELOGENOUS LEUKEMIA | RHEUMATOID-ARTHRITIS | COLLAGEN-INDUCED ARTHRITIS | scaffold-based drug design | COLONY-STIMULATING FACTOR | TYROSINE KINASE | MULTIDISCIPLINARY SCIENCES | MAST-CELLS | rheumatoid arthritis | PROTOONCOGENE C-KIT | cancer bone metastasis | GASTROINTESTINAL STROMAL TUMORS | OSTEOCLAST DIFFERENTIATION | IMATINIB MESYLATE | Human Umbilical Vein Endothelial Cells | Escherichia coli | Humans | Proto-Oncogene Proteins c-kit - antagonists & inhibitors | Mutation, Missense - genetics | Spodoptera | Aminopyridines - chemistry | Protein Kinase Inhibitors - chemistry | Sf9 Cells | Neoplasm Metastasis - drug therapy | Inflammation - drug therapy | Proto-Oncogene Proteins c-kit - genetics | Molecular Structure | Indoles | Cell Survival - drug effects | Oncogene Protein gp140(v-fms) - genetics | Protein Kinase Inhibitors - chemical synthesis | Oncogene Protein gp140(v-fms) - antagonists & inhibitors | Crystallization | Models, Molecular | Mast Cells - drug effects | Aminopyridines - chemical synthesis | Pyrroles - pharmacology | Animals | Chromatography, Affinity | Pyrroles - chemical synthesis | Aminopyridines - pharmacology | Pyrroles - chemistry | Macrophages - drug effects | Protein Conformation | Protein Kinase Inhibitors - pharmacology | Oncogene Protein gp140(v-fms) - chemistry | Proto-Oncogene Proteins c-kit - chemistry | Osteoclasts - drug effects | Cell receptors | Care and treatment | Pharmacology, Experimental | Cancer cells | Physiological aspects | Research | Properties | Oncogenes | Immune system | Inhibitor drugs | Research & development--R&D | Medical treatment | Pharmacology | Kinases | Inflammatory diseases | Index Medicus | Biological Sciences
Journal Article
Cancer Discovery, ISSN 2159-8274, 06/2015, Volume 5, Issue 6, pp. 668 - 679
Tyrosine kinase domain mutations are a common cause of acquired clinical resistance to tyrosine kinase inhibitors (TKIs) used to treat cancer, including the... 
Resistance | Gatekeeper Mutations | Quizartinib | FLT3
Journal Article
Journal Article
CANCER DISCOVERY, ISSN 2159-8274, 06/2015, Volume 5, Issue 6, pp. 668 - 679
Journal Article
Journal Article
Genetics, ISSN 0016-6731, 06/2004, Volume 167, Issue 2, p. 761
  The Berkeley Drosophila Genome Project (BDGP) strives to disrupt each Drosophila gene by the insertion of a single transposable element. As part of this... 
Genetics | Mutation | Insects | Genomics | Genes | STRAINS | DROSOPHILA TRANSPOSON P-ELEMENT PIGGYBAC MUTAGENESIS | MUTAGENESIS | DISTRIBUTION | BASIC BIOLOGICAL SCIENCES | GENETICS | PROMOTERS | GENES | TRANSPOSONS | DROSOPHILA
Journal Article
12/2018
or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein R1, R2, Q1, Q2, and Q3, are described in this... 
METALLURGY | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | HETEROCYCLIC COMPOUNDS | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
11/2016
or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein R1, R2, Q1, Q2, and Q3, are described in this... 
METALLURGY | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | HETEROCYCLIC COMPOUNDS | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
10/2016
Compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein R1, R2, Q1, Q2, and... 
METALLURGY | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | HETEROCYCLIC COMPOUNDS | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
Journal Article